NCT00421174 2021-11-01BMTCTN0403National Heart, Lung, and Blood Institute (NHLBI)Phase 3 Completed37 enrolled 20 charts
NCT01241591 2018-12-26A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque PsoriasisPfizerPhase 3 Completed1,101 enrolled 46 charts
NCT00357903 2017-02-09Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical TrialsAmgenPhase 3 Completed639 enrolled 27 charts